<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-4085</journal-id>
<journal-title><![CDATA[Revista mexicana de urología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. urol.]]></abbrev-journal-title>
<issn>2007-4085</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Urología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-40852017000200097</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Urinary tract infection etiology and antimicrobial sensitivity in a Mexican hospital from 2010 to 2015]]></article-title>
<article-title xml:lang="es"><![CDATA[Etiología de las infecciones urinarias y sensibilidad antimicrobiana en un hospital mexicano (2010-2015)]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Villalobos-Ayala]]></surname>
<given-names><![CDATA[JL.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Licea-Serrato]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado Hospital Regional Department of Urology]]></institution>
<addr-line><![CDATA[Monterrey Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Autónoma de Nuevo León School of Odontología ]]></institution>
<addr-line><![CDATA[Monterrey Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado Hospital Regional Department of Infectology]]></institution>
<addr-line><![CDATA[Monterrey Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2017</year>
</pub-date>
<volume>77</volume>
<numero>2</numero>
<fpage>97</fpage>
<lpage>105</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-40852017000200097&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-40852017000200097&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-40852017000200097&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  BACKGROUND:  urinary tract infections are common in both community-based and hospitalized patients. The complexity of their management is increasing, as a result of antimicrobial resistance.  OBJECTIVE:  to assess the prevalence and antimicrobial susceptibility profile of uropathogens present in urine cultures analyzed at the Hospital Regional ISSSTE, Monterrey, Nuevo Léon, Mexico.  MATERIALS AND METHODS:  a retrospective cohort study was conducted, based on urine sample analyses performed at the hospital laboratory between January 2010 and September 2015.  RESULTS:  data on 4,394 urine cultures were obtained. Escherichia coli was identified in 47.1% of the isolates. A total of 59.4% of the Escherichia coli and 59.6% of the Klebsiella pneumoniae isolates showed production of extended-spectrum beta-lactamases. Candida albicans was found in 3.6% of the isolates. Most of the Escherichia coli and Klebsiella pneumoniae isolates showed sensitivity to carbapenems.  CONCLUSIONS:  these study results provide valuable insight for improving urinary tract infection management at the Hospital Regional ISSSTE of Monterrey. Institutions elsewhere should carry out these investigations, to understand antimicrobial resistance trends in their area of activity and improve their antimicrobial prescription practices.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  ANTECEDENTES:  la infección urinaria es frecuente en pacientes ambulatorios y hospitalizados. La complejidad de su tratamiento está aumentando como consecuencia de la resistencia antimicrobiana.  OBJETIVO:  evaluar en cultivos de orina la prevalencia y perfil de sensibilidad antimicrobiana de los uropatógenos analizados en el Hospital Regional del ISSSTE, Monterrey, Nuevo León, México.  MATERIAL Y MÉTODOS:  estudio de cohorte, retrospectivo, de muestras de orina analizadas entre enero de 2010 y septiembre de 2015.  RESULTADOS: se obtuvieron datos de 4394 urocultivos en los que se identificó Escherichia coli en 47.1% de los aislamientos. El 59.4% de los aislados de E. coli y 59.6% de los aislados de Klebsiella pneumoniae (K. pneumoniae) mostraron producción de betalactamasas de amplio espectro. Candida albicans se encontró en 3.6% de los aislamientos. La mayor parte de los aislados de E. coli y de K. pneumoniae mostraron sensibilidad a carbapenémicos.  CONCLUSIONES: estos resultados proporcionan valiosa información para el mejor tratamiento de pacientes con infección de vías urinarias en el Hospital Regional del ISSSTE de Monterrey. Las demás instituciones deberían efectuar estas investigaciones para comprender las tendencias de resistencia antimicrobiana en su área de actividad y, de esta manera, mejorar las prácticas de prescripción de antimicrobianos.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[infecciones urinarias]]></kwd>
<kwd lng="es"><![CDATA[ITU]]></kwd>
<kwd lng="es"><![CDATA[uropatógenos]]></kwd>
<kwd lng="es"><![CDATA[sensibilidad antimicrobiana]]></kwd>
<kwd lng="en"><![CDATA[urinary tract infection]]></kwd>
<kwd lng="en"><![CDATA[UTI]]></kwd>
<kwd lng="en"><![CDATA[uropathogens]]></kwd>
<kwd lng="en"><![CDATA[antimicrobial sensitivity]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foxman]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden]]></article-title>
<source><![CDATA[Infect Dis Clin North Am]]></source>
<year>2014</year>
<volume>28</volume>
<page-range>1-13</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schappert]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Rechtsteiner]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ambulatory medical care utilization estimates for 2007]]></article-title>
<source><![CDATA[Vital Health Stat]]></source>
<year>2011</year>
<volume>13</volume>
<page-range>1-38</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Dirección General de Epidemiología de México</collab>
<source><![CDATA[Distribución de casos nuevos de enfermedad por grupos de edad. Estados Unidos Mexicanos 2014. Población General]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bours]]></surname>
<given-names><![CDATA[PHA]]></given-names>
</name>
<name>
<surname><![CDATA[Polak]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hoepelman]]></surname>
<given-names><![CDATA[AIM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines]]></article-title>
<source><![CDATA[Int J Infect Dis]]></source>
<year>2010</year>
<volume>14</volume>
<page-range>e770-4</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez-Hernández]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Amaro-Ortega]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Costos atribuibles y factores de riesgo de infección nosocomial en un Hospital Pediátrico del Estado de Sonora, 2008]]></article-title>
<source><![CDATA[Bol Méd Hosp Infant México]]></source>
<year>2010</year>
<volume>67</volume>
<page-range>118-27</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foxman]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of Urinary Tract Infections: Incidence, Morbidity, and Economic Costs]]></article-title>
<source><![CDATA[Dis Mon]]></source>
<year>2003</year>
<volume>49</volume>
<page-range>53-70</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>Sistema Nacional de Vigilancia Epidemiológica</collab>
<source><![CDATA[Panorama Epidemiológico de las Infecciones de Vías Urinarias en México 2003-2008]]></source>
<year>2009</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hooton]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Naber]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2011</year>
<volume>52</volume>
<page-range>e103-20</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bouza]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[San Juan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection]]></article-title>
<source><![CDATA[Clin Microbiol Infect]]></source>
<year>2001</year>
<volume>7</volume>
<page-range>532-42</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grigoryan]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Trautner]]></surname>
<given-names><![CDATA[BW]]></given-names>
</name>
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis and management of urinary tract infections in the outpatient setting: a review]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2014</year>
<volume>312</volume>
<page-range>1677-84</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boyle]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Zembower]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum &#946;-Lactamases and Beyond]]></article-title>
<source><![CDATA[Urol Clin North Am]]></source>
<year>2015</year>
<volume>42</volume>
<page-range>493-505</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gales]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Sader]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000)]]></article-title>
<source><![CDATA[Diagn Microbiol Infect Dis]]></source>
<year>2002</year>
<volume>44</volume>
<page-range>289-99</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gales]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Gordon]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Sader]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998)]]></article-title>
<source><![CDATA[J Antimicrob Chemother]]></source>
<year>2000</year>
<volume>45</volume>
<page-range>295-303</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morrissey]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Hackel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Badal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011]]></article-title>
<source><![CDATA[Pharm Basel Switz]]></source>
<year>2013</year>
<volume>6</volume>
<page-range>1335-46</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cornejo-Juárez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Velásquez-Acosta]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Sandoval]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patrones de resistencia bacteriana en urocultivos en un hospital oncológico]]></article-title>
<source><![CDATA[Salud Pública México]]></source>
<year>2007</year>
<volume>49</volume>
<page-range>330-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-Martínez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Calderón-Jaimes]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Olivar-López]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Susceptibilidad antimicrobiana de microorganismos causantes de infección de vías urinarias bajas en un hospital pediátrico]]></article-title>
<source><![CDATA[Bol Méd Hosp Infant México]]></source>
<year>2014</year>
<volume>71</volume>
<page-range>339-45</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Morúa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Torres]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar-de-Hoyos]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Community-acquired urinary tract infection etiology and antibiotic resistance in a Mexican population group]]></article-title>
<source><![CDATA[Rev Mex Urol]]></source>
<year>2009</year>
<volume>69</volume>
<page-range>45-8</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arreguín]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Cebada]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Simón]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Microbiología de las infecciones urinarias en pacientes ambulatorios. Opciones terapéuticas en tiempos de alta resistencia a los antibiótico]]></article-title>
<source><![CDATA[Rev Investig Clínica]]></source>
<year>2007</year>
<volume>59</volume>
<page-range>239-45</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Flamm]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
<name>
<surname><![CDATA[Sader]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011)]]></article-title>
<source><![CDATA[Braz J Infect Dis]]></source>
<year>2014</year>
<volume>18</volume>
<page-range>187-95</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pitout]]></surname>
<given-names><![CDATA[JDD]]></given-names>
</name>
<name>
<surname><![CDATA[Nordmann]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Laupland]]></surname>
<given-names><![CDATA[KB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community]]></article-title>
<source><![CDATA[J Antimicrob Chemother]]></source>
<year>2005</year>
<volume>56</volume>
<page-range>52-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nakai]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hagihara]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kato]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence and risk factors of infections caused by extended-spectrum &#946;-lactamase (ESBL)-producing Enterobacteriaceae]]></article-title>
<source><![CDATA[J Infect Chemother]]></source>
<year>2016</year>
<volume>22</volume>
<page-range>319-26</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franiczek]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Krzyzanowska]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Dolna]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Extended-spectrum beta-lactamase-conferring transferable resistance to different antimicrobial agents in Enterobacteriaceae isolated from bloodstream infections]]></article-title>
<source><![CDATA[Folia Microbiol]]></source>
<year>2005</year>
<volume>50</volume>
<page-range>119-24</page-range><publisher-loc><![CDATA[Praha ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franiczek]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dolna]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Krzyzanowska]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transferable resistance to different antimicrobials due to CTX-M-type &#946;-lactamases among Citrobacter freundii, Serratia marcescens, and Enterobacter spp. clinical isolates]]></article-title>
<source><![CDATA[Adv Clin Exp Med]]></source>
<year>2007</year>
<volume>16</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>493-500</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez-Baño]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Navarro]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Ngugro]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Extendedspectrum beta-lactamases in ambulatory care: a clinical perspective]]></article-title>
<source><![CDATA[Clin Microbiol Infect]]></source>
<year>2008</year>
<volume>14</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>104-10</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ozhak-Baysan]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Ogunc]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Colak]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria]]></article-title>
<source><![CDATA[Med Mycol]]></source>
<year>2012</year>
<volume>50</volume>
<page-range>529-32</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kauffman]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Vazquez]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Sobel]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2000</year>
<volume>30</volume>
<page-range>14-8</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aubron]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Suzuki]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Glassford]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The epidemiology of bacteriuria and candiduria in critically ill patients]]></article-title>
<source><![CDATA[Epidemiol Infect]]></source>
<year>2015</year>
<volume>143</volume>
<page-range>653-62</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Padawer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pastukh]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Nitzan]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Catheter-associated candiduria: Risk factors, medical interventions, and antifungal susceptibility]]></article-title>
<source><![CDATA[Am J Infect Control]]></source>
<year>2015</year>
<volume>43</volume>
<page-range>e19-22</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Y-H]]></given-names>
</name>
<name>
<surname><![CDATA[Ko]]></surname>
<given-names><![CDATA[W-C]]></given-names>
</name>
<name>
<surname><![CDATA[Hsueh]]></surname>
<given-names><![CDATA[P-R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens]]></article-title>
<source><![CDATA[Eur J Clin Microbiol Infect Dis]]></source>
<year>2012</year>
<volume>31</volume>
<page-range>1699-704</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pitout]]></surname>
<given-names><![CDATA[JDD]]></given-names>
</name>
<name>
<surname><![CDATA[Laupland]]></surname>
<given-names><![CDATA[KB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Extended-spectrum betalactamase-producing Enterobacteriaceae: an emerging public-health concern]]></article-title>
<source><![CDATA[Lancet Infect Dis]]></source>
<year>2008</year>
<volume>8</volume>
<page-range>159-66</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chatterjee]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Anju]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Biswas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options]]></article-title>
<source><![CDATA[Int J Med Microbiol]]></source>
<year>2016</year>
<volume>306</volume>
<page-range>48-58</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Gales]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001)]]></article-title>
<source><![CDATA[J Antimicrob Chemother]]></source>
<year>2003</year>
<volume>52</volume>
<page-range>140-1</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cunha]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Schoch]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Hage]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nitrofurantoin: Preferred Empiric Therapy for Community-Acquired Lower Urinary Tract Infections]]></article-title>
<source><![CDATA[Mayo Clin Proc]]></source>
<year>2011</year>
<volume>86</volume>
<page-range>1243-4</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Munoz-Davila]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Role of Old Antibiotics in the Era of Antibiotic Resistance. Highlighted Nitrofurantoin for the Treatment of Lower Urinary Tract Infections]]></article-title>
<source><![CDATA[Antibiotics]]></source>
<year>2014</year>
<volume>3</volume>
<page-range>39-48</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morfin-Otero]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Noriega]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Dowzicky]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial]]></article-title>
<source><![CDATA[Ann Clin Microbiol Antimicrob]]></source>
<year>2015</year>
<volume>14</volume>
<page-range>53</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Guzman-Blanco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gales]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)]]></article-title>
<source><![CDATA[Braz J Infect Dis]]></source>
<year>2013</year>
<volume>17</volume>
<page-range>672-81</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kauffman]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis and management of fungal urinary tract infection]]></article-title>
<source><![CDATA[Infect Dis Clin North Am]]></source>
<year>2014</year>
<volume>28</volume>
<page-range>61-74</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Tracy]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of Fungal Urinary Tract Infection]]></article-title>
<source><![CDATA[Urol Clin North Am]]></source>
<year>2015</year>
<volume>42</volume>
<page-range>473-83</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chaari]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ismail]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Abdel Hakim]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness of Systemic Fluconazole in Adult Patients With Asymptomatic Candiduria: A Systematic Review and Meta-Analysis]]></article-title>
<source><![CDATA[Am J Ther]]></source>
<year>2016</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
